Suppression of cytochrome P450 1A1 expression induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse hepatoma hepa-1c1c7 cells treated with serum of (-)-epigallocatechin-3-gallate-and green tea extract-administered rats

Bioscience, Biotechnology and Biochemistry

Volumn 73, Issue 5, 2009, Pages 1206-1208

  Fukuda, Itsuko ^a   Tsutsui, Miki ^a   Sakane, Iwao ^b   Ashida, Hitoshi ^a  

^a KOBE UNIVERSITY   (Japan)

^b 421 0516   (Japan)

Author keywords

Cytochrome P450 1A1Dioxin; Hepatocyte; Rat plasma catechin; Tea catechin

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1DIOXIN; EPIGALLOCATECHIN-3-GALLATE; GREEN TEA EXTRACTS; HEPATOCYTE; RAT PLASMA; RAT PLASMA CATECHIN; RAT SERUM; TEA CATECHIN; TETRACHLORODIBENZO P DIOXINS;

BODY FLUIDS; ORGANIC COMPOUNDS; PLASMA (HUMAN); PLASMAS; RATS; VITAMINS;

PHENOLS;

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CATECHIN; CYTOCHROME P450 1A1; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; PLANT EXTRACT;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL CARCINOMA; MALE; METABOLISM; MOUSE; PATHOLOGY; RAT; TEA; TUMOR CELL LINE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CATECHIN; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; PLANT EXTRACTS; RATS; TEA; TETRACHLORODIBENZODIOXIN;

RATTUS;

EID: 67049119278     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80868     Document Type: Article

References (21)

1. De Vito MJ and Birnbaum LS, "Dioxins and Health," ed. Schecter A, Plenum, New York, pp. 139-162 (1994).
2. Whitlock JPJr, Annu. Rev. Pharmacol. Toxicol., 30, 251-277 (1990).
3. Denison MS, Phelan D, and Elferink CJ, "Toxicant-Receptor Interactions," eds. Denison MS and Helferich WG, Taylor and Francis, Philadelphia, pp. 3-33 (1998).
4. Schrenk D, Biochem. Pharmacol., 55, 1155-1162 (1998).
5. Rowlands JC and Gustaffson JA° , Crit. Rev. Toxicol., 27, 109-134 (1997).
6. Whitlock JPJr, Chem. Res. Toxicol., 6, 745-753 (1993).
7. Hankinson O, Annu. Rev. Pharmacol. Toxicol., 35, 307-340 (1995).
8. Denison MS, Fisher JM, and Whitlock JPJr, J. Biol. Chem., 263, 17221-17224 (1988).
9. Ashida H, Fukuda I, Yamashita T, and Kanazawa K, FEBS Lett., 476, 213-217 (2000).
10. Fukuda I, Sakane I, Yabushita Y, Kodoi R, Nishiumi S, Kakuda T, Sawamura S, Kanazawa K, and Ashida H, J. Agric. Food Chem., 52, 2499-2506 (2004).
11. Netsch MI, Gutmann H, Schmidlin CB, Aydogan C, and Drewe J, Planta Med., 72, 514-520 (2006).
12. Yang SP and Raner GM, Toxicol. Appl. Pharmacol., 202, 140-150 (2005).
13. Maliakal PP and Wanwimolruk S, J. Pharm. Pharmacol., 53, 1323-1329 (2001).
14. Maliakal PP, Coville PF, and Wanwimolruk S, J. Pharm. Pharmacol., 53, 569-577 (2001).
15. Lee MJ, Prabhu S, Meng X, Li C, and Yang CS, Anal. Biochem., 279, 164-169 (2000).
16. Mulder TP, van Platerink CJ, Wijnand Schuyl PJ, and van Amelsvoort JM, J. Chromatogr. B Biomed. Sci. Appl., 760, 271-279 (2001).
17. Goto T, Yoshida Y, Kiso M, and Nagashima H, J. Chromatogr. A, 749, 295-299 (1996).
18. Garside H, Stewart A, Brown N, Cooke EL, Graham M, and Sullivan M, Xenobiotica, 38, 1-20 (2008).
19. Kashiwada D, Fukuda I, Yoshida K, and Ashida H, J. Clin. Biochem. Nutr., 43S1, 460-463 (2008).
20. Chen L, Lee MJ, Li H, and Yang CS, Drug Metab. Dispos., 25, 1045-1050 (1997).
21. Lambert JD, Sang S, and Yang CS, Mol. Pharm., 4, 819-825 (2007).